ABT ▲ +1.6% - Abbott Laboratories
$ABT Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System
01-NOV-2026 05:15 PM ET
Share this post
More filings for $ABT
ABT ▲ +1.5% - Abbott LaboratoriesOct 29, 2026ABT ▲ +0.0% - Abbott LaboratoriesOct 26, 2026ABT ▼ -0.4% - Abbott LaboratoriesOct 23, 2026ABT ▼ -3.4% - Abbott LaboratoriesOct 21, 2026ABT ▼ -1.6% - Abbott LaboratoriesOct 21, 2026ABT ▼ -1.6% - Abbott LaboratoriesOct 21, 2026
View full $ABT filing history →💬 Comments
Loading comments…
Leave a comment